SURF Surface Oncology Inc

Surface Oncology Inc is a clinical-stage immuno-oncology company. It is developing new therapies that modify the spaces in and around tumors the tumor microenvironment to create conditions that support and sustain anti-tumor immune responses.

As of 10/05/2022     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/19/2018
Outstanding shares:  58,034,033
Average volume:  330,704
Market cap:   $63,257,096
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      BZ57GY6
Valuation   (See tab for details)
PE ratio:   -1.23
PB ratio:   0.47
PS ratio:   2.04
Return on equity:   -38.59%
Net income %:   -182.62%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy